SCHEMBL6878640

SCHEMBL6878640

CC(OC(=O)OC1CCCCC1)OC(=O)c1cccc2[nH]ccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 11/20 0.41
▸ ADRB2 P07550 2/20 0.41
▸ ADRB1 P08588 2/20 0.41
▸ CHRM2 P08172 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ MLNR O43193 1/20 0.40
▸ NR1I2 O75469 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ ESR1 P03372 1/20 0.40
▸ NR3C1 P04150 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ PGR P06401 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40
▸ GABRA1 P14867 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ ADRA2B P18089 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5305864 0.81 PARP1 (0.44) HTR1AADRB2ADRB1CHRM2KDM4E
SCHEMBL6875889 0.79 TUBB4A (0.44) KDM4ETUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5305861 0.78 HPGD (0.45) HTR1AADRB2ADRB1CHRM2KDM4E
SCHEMBL7496719 0.76 KDM4E (0.54) KDM4ETP53HPGDKMT2AHSD17B10
SCHEMBL6865989 0.76 ACHE (0.41) CHRM2CYP3A4CNR1SLC6A2SLC6A3
SCHEMBL25920617 0.74 LMNA (0.56) CHRM2MEN1TP53CHRM3KMT2A
SCHEMBL25913609 0.71 SCN1A (0.48) MEN1HPGDKMT2A
SCHEMBL9872973 0.70 HTR3A (0.66) HTR1ACYP3A4ADRA2BADRA2CCHRM3
SCHEMBL24848168 0.70 MEN1 (0.46) MEN1TP53KMT2A
SCHEMBL5010378 0.70 PARP10 (0.44) MEN1KMT2APDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451185-A1 INDOLE-2-CARBOXAMIDES AS FACTOR XA INHIBITORS Aventis Pharma Deutschland GmbH (DE) 2004-09-01 — — EP disclosed
WO-2003044014-A1 INDOLE-2-CARBOXAMIDES AS FACTOR XA INHIBITORS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-05-30 — — WO disclosed
Send feedback